Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
3d
The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...
Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which ...
1d
People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.
Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...
We meet some of the first NHS patients, as expert says funding everyone eligible would "bankrupt" the service.
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
Some people may turn to private healthcare providers in order to get their hands on the weight loss jabs. However, Britons ...
More than 90 per cent of weight loss jab users are forced to pay for treatment privately due to their slow roll-out on the ...
Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback